Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy.

MLA

Mayoux, Maud, et al. “Dendritic Cells Dictate Responses to PD-L1 Blockade Cancer Immunotherapy.” Science Translational Medicine, vol. 12, no. 534, Mar. 2020, pp. 1–11. EBSCOhost, https://doi.org/10.1126/scitranslmed.aav7431.

APA

Mayoux, M., Roller, A., Pulko, V., Sammicheli, S., Chen, S., Sum, E., Jost, C., Fransen, M. F., Buser, R. B., Kowanetz, M., Rommel, K., Matos, I., Colombetti, S., Belousov, A., Karanikas, V., Ossendorp, F., Hegde, P. S., Chen, D. S., Umana, P., & Perro, M. (2020). Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy. Science Translational Medicine, 12(534), 1–11. https://doi.org/10.1126/scitranslmed.aav7431

Chicago

Mayoux, Maud, Andreas Roller, Vesna Pulko, Stefano Sammicheli, Stanford Chen, Eva Sum, Christian Jost, et al. 2020. “Dendritic Cells Dictate Responses to PD-L1 Blockade Cancer Immunotherapy.” Science Translational Medicine 12 (534): 1–11. doi:10.1126/scitranslmed.aav7431.